Monday, August 27, 2018

Excessive Drooling ? New Treatment Approved by FDA

  Xeomin (incobotulinumtoxinA) for the treatment of chronic sialorrhea in adults (ages 20-80) such as that seen in Parkinson's disease. Also those adults with cerebral palsy, MSA, PSP.
  100 units is injected into 4 sites in submandibular glands bilaterally.
  NB! Exclusionary criteria: patients on coumadin, + history of Myesthenia Gravis, Lambert-Eaton syndrome, ongoing substance abuse, cognitive impairment < 23/30 on Mini Mental Status exam.
  I use atropine opthalmic drops under the tongue with great success in select patients in my practice. ID : NCTO1653132

No comments:

Post a Comment